Connect with us

Latest News

Drugs for benign prostatic hypertrophy can lead to prostate cancer, so its treatment should be safe

Published

on

Drugs for benign prostatic hypertrophy can lead to prostate cancer, so its treatment should be safe

Benign prostatic hypertrophy and prostate cancer may have the same symptoms, but the treatment must differ. Benign prostatic hypertrophy is a non-life-threatening but ageing condition, therefore this metabolic problem innovative should be safe in the first place.

Benign prostatic hypertrophy develops slowly squeezing bladder that leads to annoying lower urinary tract symptoms (LUTS), such as frequent or urgent need to urinate; increased frequency of urination at night; difficulty with starting urination; weak urine stream and others. Therefore, the cessation of the growth of the prostate gland is the main goal, when men choose the treatment option for benign prostatic hypertrophy.

Benign prostatic hypertrophy drugs are risky

In 2019 a French population‐based study investigated a total of 963 patients with benign prostatic hypertrophy who received medical therapy. It was concluded that patients treated for >2 years with 5α-reductase inhibitors (5‐ARIs) should be informed about the increased risk of development of high-grade prostate cancer.

Previously 5‐ARIs medications such as Proscar and Avodart were found responsible for impotence, increase blood sugar and blood lipids, so it can cause diabetes and a heart attack. 5‐ARIs often used with other drugs – Alfa-blockers, which are responsible for sexual dysfunction, fatigue. However, the use of both drugs together does not reduce the risk of prostate cancer development.

Dr. Allen’s Device provides the first safe therapy for the prostate gland.

Thermobalancing therapy with Dr. Allen’s therapeutic for over 10 years has been successfully used by thousands of customers in over 100 countries. Therefore, Dr. Allen’s Device should be administered to men, as the first-line treatment for benign prostatic hypertrophy.

Dr. Allen’s device relieves LUTS due to benign prostatic hypertrophy as it terminates prostate enlargement. A large clinical trial has confirmed that Dr. Allen’s device decreases the size of the enlarged prostate that reduces the pressure on the urethra and, consequently, a man gets relief from urination symptoms.

It is important as, by the age of 60, 50% of men will suffer lower LUTS. Today, as life expectancy increases, the administration of risky drugs to men with benign prostatic hypertrophy should be prescribed as a short-term therapy.

Thermobalancing therapy helps without complications.

Dr. Allen’s Device is a class 1 medical device, which does not require the involvement of a notified body at any country. So, everyone can use it at home without worrying, as this treatment option causes no side effects.

Thermobalancing therapy with Dr. Allen’s Device was patented by the United States Patent and Trademark Office. This is compelling evidence that this is a completely new treatment for chronic diseases, including an enlarged prostate.

Over a decade, many men suffering from benign prostatic hypertrophy are using this non-invasive and side-effects free Dr. Allen’s Device. It helped them to manage this chronic condition easily. Fine Treatment, an innovative healthcare company, manufactures and delivers this device worldwide to every customer. The delivery of Dr. Allen’s Device is guaranteed by the Royal mail service.

Advertisement

Trending

error: Content is protected !!